Table 3

Baseline characteristics of enrolled patients, overall and by type of SDB

OverallType of SDB*P value
CSAeCSA or co-ex CSA/OSA
n (%)503 (100)345 (69)156 (31)
Male, n (%)442 (88)311 (90.1)131 (84)0.05
Age, years72 (64–79)72 (65–79)73 (65–78)0.93
Body mass index, kg/m228 (25–32)27 (24–32)30 (26–32)0.01
Current smoker, n (%)232 (46)166 (48)66 (43)0.24
Alcohol use, n (%)66 (14)58 (17)11 (7)<0.01
 Cardiac devices†, n (%)136 (27)84 (25)52 (33)0.04
Heart failure aetiology, n (%)
 Ischaemic259 (52)182 (53)77 (51)0.19
 Dilated cardiomyopathy36 (7)25 (7)11 (7)
 Arterial hypertension73 (15)45 (13)28 (18)
 Valvular31 (8)31 (9)7 (5)
 Alcoholic5 (1)5 (2)0 (0)
 Other85 (17)56 (16)29 (19)
LVEF, %49 (34–58)48 (35–58)50 (33–57)0.87
NYHA class, n (%)*‡
 I82 (19)62 (20.1)20 (15.5)0.30
 II190 (43)138 (44.7)52 (40.3)
 III146 (33)97 (31.4)49 (38)
 IV20 (5)12 (3.9)8 (6.2)
Comorbidities, n (%)
 Arterial hypertension360 (72)249 (72)111 (72)0.90
 Diabetes mellitus188 (38)127 (37)61 (39)0.59
 Dyslipidaemia292 (58)202 (59)90 (58)0.86
 Stroke/TIA113 (23)84 (24)29 (19)0.16
 Atrial fibrillation202 (40)140 (41)62 (40)0.86
 Other arrhythmias96 (19)65 (19)31 (20)0.77
 COPD58 (12)38 (11)20 (13)0.56
 Depression36 (7)20 (6)16 (10)0.07
  • Values are median (IQR) or number of patients (%).

  • *Type of sleep-disordered breathing data were unavailable in two patients.

  • †Cardiac device implanted: pacemaker or defibrillator.

  • ‡NYHA class data were available in 438 patients of the 501 patients with polygraphy or polysomnography data; percentages are reported using the whole population as the denominator (the difference from 100% is missing data).

  • Co-ex CSA/OSA, coexisting central sleep apnoea/obstructive sleep apnoea; COPD, chronic obstructive pulmonary disease; eCSA, emergent central sleep apnoea; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; SDB, sleep-disordered breathing; TIA, transient ischaemic attack.